Amrize (AMRZ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Executive summary
Annual General Meeting scheduled for April 21, 2026, in Zug, Switzerland, with voting open until April 16, 2026.
Shareholders will vote on financial statements, executive compensation, board elections, and distributions.
Voting matters and shareholder proposals
Approval of the 2025 Annual Report, consolidated and statutory financial statements.
Advisory votes on executive compensation, frequency of say-on-pay, and Swiss Statutory Remuneration Report.
Advisory vote on the Non-Financial Matters Report for 2025.
Approval of offsetting accumulated losses and special/regular distributions from capital reserves (up to $0.44/share, up to four installments).
Discharge of board and executive management from liability for 2025 activities.
Board of directors and corporate governance
Re-election of nine current board members and election of two new members.
Re-election of Jan Jenisch as Chairman of the Board.
Re-election of three members to the Compensation Committee.
Latest events from Amrize
- 2026 AGM proxy covers key votes, governance, compensation, and ESG priorities.AMRZ
Proxy Filing12 Mar 2026 - 2026 AGM proxy covers financials, compensation, board elections, and strong governance initiatives.AMRZ
Proxy Filing27 Feb 2026 - 2026 guidance targets 4–6% revenue and 8–11% EBITDA growth, with strong shareholder returns.AMRZ
Q4 202518 Feb 2026 - Stable Q2 2025 results and synergy program support strong outlook and long-term growth.AMRZ
Q2 202523 Nov 2025 - Q3 revenue up 6.6% to $3,675M, net income $543M, 2025 guidance raised to $12.0B.AMRZ
Q3 202529 Oct 2025